索引于
  • 学术期刊数据库
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 期刊目录
  • 中国知网(CNKI)
  • 乌尔里希的期刊目录
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-WorldCat
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Meeting Patient Needs in Hereditary Angioedema Care

Autumn Ford Burnette

Hereditary angioedema (HAE) is a rare, chronic disease that causes recurrent episodes of severe swelling in the face, airways, limbs, and intestinal tract. Recent advances have provided HAE patients with more treatment options. My research and the work of others have investigated patient preferences and perspectives on available HAE prophylactic treatments. Increasing numbers of patients are taking prophylactic medication for HAE (primarily injectable) and most are satisfied with their current treatments. Nonetheless, as alternative treatments become available, their preferences may shift, with many patients expressing a desire for alternative routes of administration. Healthcare providers should have an ongoing, open dialogue with their patients regarding which HAE treatments are best for their needs.